Cargando…
P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431083/ http://dx.doi.org/10.1097/01.HS9.0000970420.62475.d0 |
| _version_ | 1785091115566759936 |
|---|---|
| author | Sidana, Surbhi Moreau, Philippe Garfall, Alfred Bhutani, Manisha Oriol, Albert Nooka, Ajay Martin, Tom Rosiñol Dachs, Laura Mateos, Maria-Victoria Bahlis, Nizar J Popat, Rakesh Besemer, Britta Martinez-Lopez, Joaquín Krishnan, Amrita Delforge, Michel Trancucci, Danielle Verona, Raluca Stephenson, Tara Chastain, Katherine van de Donk, Niels W.C.J. |
| author_facet | Sidana, Surbhi Moreau, Philippe Garfall, Alfred Bhutani, Manisha Oriol, Albert Nooka, Ajay Martin, Tom Rosiñol Dachs, Laura Mateos, Maria-Victoria Bahlis, Nizar J Popat, Rakesh Besemer, Britta Martinez-Lopez, Joaquín Krishnan, Amrita Delforge, Michel Trancucci, Danielle Verona, Raluca Stephenson, Tara Chastain, Katherine van de Donk, Niels W.C.J. |
| author_sort | Sidana, Surbhi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431083 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104310832023-08-17 P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) Sidana, Surbhi Moreau, Philippe Garfall, Alfred Bhutani, Manisha Oriol, Albert Nooka, Ajay Martin, Tom Rosiñol Dachs, Laura Mateos, Maria-Victoria Bahlis, Nizar J Popat, Rakesh Besemer, Britta Martinez-Lopez, Joaquín Krishnan, Amrita Delforge, Michel Trancucci, Danielle Verona, Raluca Stephenson, Tara Chastain, Katherine van de Donk, Niels W.C.J. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431083/ http://dx.doi.org/10.1097/01.HS9.0000970420.62475.d0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Sidana, Surbhi Moreau, Philippe Garfall, Alfred Bhutani, Manisha Oriol, Albert Nooka, Ajay Martin, Tom Rosiñol Dachs, Laura Mateos, Maria-Victoria Bahlis, Nizar J Popat, Rakesh Besemer, Britta Martinez-Lopez, Joaquín Krishnan, Amrita Delforge, Michel Trancucci, Danielle Verona, Raluca Stephenson, Tara Chastain, Katherine van de Donk, Niels W.C.J. P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title | P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_full | P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_fullStr | P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_full_unstemmed | P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_short | P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) |
| title_sort | p879: long-term follow-up from majestec-1 of teclistamab, a b-cell maturation antigen (bcma) x cd3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (rrmm) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431083/ http://dx.doi.org/10.1097/01.HS9.0000970420.62475.d0 |
| work_keys_str_mv | AT sidanasurbhi p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT moreauphilippe p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT garfallalfred p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT bhutanimanisha p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT oriolalbert p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT nookaajay p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT martintom p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT rosinoldachslaura p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT mateosmariavictoria p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT bahlisnizarj p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT popatrakesh p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT besemerbritta p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT martinezlopezjoaquin p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT krishnanamrita p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT delforgemichel p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT trancuccidanielle p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT veronaraluca p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT stephensontara p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT chastainkatherine p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm AT vandedonknielswcj p879longtermfollowupfrommajestec1ofteclistamababcellmaturationantigenbcmaxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomarrmm |